Yet, although anatomopathological studies on GPER expression are not included in routine clinical practices, in the case of estrogen-dependent tumors and especially BC, several works show that its altered expression can be associated with cancer progression, supporting a potential prognostic value (67–69). This evidence concerns the gene GPER1 and breast cancer.